NASDAQ · Medical - Healthcare Information Services

SDGR (SDGR) Stock

$15.14 -1.37% NASDAQ: SDGR Healthcare

Valuation

MetricValue
Price$15.14
Market Cap$1.13B
P/E Ratio-8.97
P/B Ratio2.60
P/S Ratio3.53
EPS (TTM)$-1.41
52-Week High$23.75
52-Week Low$10.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-28.30%
ROA-14.19%
ROCE-45.88%
Gross Margin-65.23%
Operating Margin-65.23%
Net Margin-40.60%
Debt/Equity0.34
Current Ratio2.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$138.0M$181.0M$217.0M$208.0M$256.0M
Operating Profit$-111.0M$-147.0M$-177.0M$-209.0M$-167.0M
Net Profit$-100.0M$-149.0M$41.0M$-187.0M$-103.0M
EPS$-1.43$-2.10$0.54$-2.57$-1.41
Op Margin-80.8%-81.1%-81.9%-100.8%-65.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$756.0M$689.0M$803.0M$823.0M$726.0M
Total Liabilities$199.0M$241.0M$254.0M$402.0M$362.0M
Cash$120.0M$90.0M$155.0M$147.0M$231.0M
Borrowings$80.0M$116.0M$128.0M$118.0M$109.0M

Latest News

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5 Business Wire · Jul 22, 2026 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jul 20, 2026 AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next 24/7 Wall St. · Jul 1, 2026 AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity 24/7 Wall St. · Jun 30, 2026 Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength? Zacks · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-71.0M$-120.0M$-137.0M$-157.0M$14.0M
Investing Cash Flow$-24.0M$82.0M$180.0M$142.0M$56.0M
Financing Cash Flow$8.0M$2.0M$9.0M$1.0M$0
Net Cash Flow$-80.0M$-28.0M$65.0M$2.0M$75.0M
Free Cash Flow$-78.0M$-128.0M$-150.0M$-165.0M$12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-16.48%
Quick Ratio2.74
Interest Coverage—
Return 1Y-34.30%
Return 3Y-69.49%
Return 5Y-76.09%

Ownership

Insiders Held3.01%
Institutions Held98.22%
Institutions Float Held101.27%
Institutional HolderSharesReport Date
Blackrock Inc.9,678,5602026-03-31
Gates Foundation Trust6,981,6642026-03-31
Rubric Capital Management LP6,000,0002026-03-31
Vanguard Portfolio Management LLC3,862,1972026-03-31
Sumitomo Mitsui Trust Group, Inc.3,190,8372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABCL $6.93 +6.13% -5.91 $2.12B 0.00%
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
EVOEvotec SE $2.01 -6.07% -3.26 $713.93M 0.00%
IMNM $23.22 +2.83% -8.13 $2.22B 0.00%
OMCL $37.15 -1.33% 99.32 $1.69B 0.00%

About SDGR

SDGR is led by CEO Ramy Farid, employs 891 people, headquartered in US, publicly traded since 2020.

SDGR stock trades at $15.14 with a market capitalization of $1.13B. The stock is valued at a price-to-earnings (P/E) ratio of -8.97, price-to-book of 2.60, price-to-sales of 3.53. Over the past 52 weeks the stock has ranged between $10.95 and $23.75, and currently trades 36.3% below its 52-week high.

On profitability, SDGR generates a return on equity (ROE) of -28.30%, return on capital employed of -45.88%, an operating margin of -65.23%, a net profit margin of -40.60%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides